Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
- PMID: 16506948
- DOI: 10.1517/17425247.3.2.205
Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
Abstract
The use of nanoparticles as drug delivery vehicles for anticancer therapeutics has great potential to revolutionise the future of cancer therapy. As tumour architecture causes nanoparticles to preferentially accumulate at the tumour site, their use as drug delivery vectors results in the localisation of a greater amount of the drug load at the tumour site; thus improving cancer therapy and reducing the harmful nonspecific side effects of chemotherapeutics. In addition, formulation of these nanoparticles with imaging contrast agents provides a very efficient system for cancer diagnostics. Given the exhaustive possibilities available to polymeric nanoparticle chemistry, research has quickly been directed at multi-functional nanoparticles, combining tumour targeting, tumour therapy and tumour imaging in an all-in-one system, providing a useful multi-modal approach in the battle against cancer. This review will discuss the properties of nanoparticles that allow for such multiple functionality, as well as recent scientific advances in the area of multi-functional nanoparticles for cancer therapeutics.
Similar articles
-
Clinical advances of nanocarrier-based cancer therapy and diagnostics.Expert Opin Drug Deliv. 2017 Jan;14(1):75-92. doi: 10.1080/17425247.2016.1205585. Epub 2016 Jul 7. Expert Opin Drug Deliv. 2017. PMID: 27339650 Review.
-
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.Eur J Pharm Biopharm. 2015 Jun;93:52-79. doi: 10.1016/j.ejpb.2015.03.018. Epub 2015 Mar 23. Eur J Pharm Biopharm. 2015. PMID: 25813885 Review.
-
Nanoparticulate carriers: an emerging tool for breast cancer therapy.J Drug Target. 2015 Feb;23(2):97-108. doi: 10.3109/1061186X.2014.958844. Epub 2014 Sep 18. J Drug Target. 2015. PMID: 25230853 Review.
-
Ligand-targeted liposomal therapies of neuroblastoma.Curr Med Chem. 2007;14(29):3070-8. doi: 10.2174/092986707782793916. Curr Med Chem. 2007. PMID: 18220743 Review.
-
Optically modulated cancer therapeutic delivery: past, present and future.Ther Deliv. 2015;6(5):545-58. doi: 10.4155/tde.15.17. Ther Deliv. 2015. PMID: 26001172 Review.
Cited by
-
Core-Shell Silver/Polymeric Nanoparticles-Based Combinatorial Therapy against Breast Cancer In-vitro.Sci Rep. 2016 Aug 5;6:30729. doi: 10.1038/srep30729. Sci Rep. 2016. PMID: 27491622 Free PMC article.
-
Controlled Release of DNA Binding Anticancer Drugs from Gold Nanoparticles with Near-Infrared Radiation.J Pharm Sci. 2023 Apr;112(4):1064-1071. doi: 10.1016/j.xphs.2022.12.001. Epub 2022 Dec 7. J Pharm Sci. 2023. PMID: 36493881 Free PMC article.
-
A polymeric nanoparticle formulation of curcumin (NanoCurc™) ameliorates CCl4-induced hepatic injury and fibrosis through reduction of pro-inflammatory cytokines and stellate cell activation.Lab Invest. 2011 Sep;91(9):1383-95. doi: 10.1038/labinvest.2011.86. Epub 2011 Jun 20. Lab Invest. 2011. PMID: 21691262 Free PMC article.
-
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery.Nat Rev Drug Discov. 2014 Nov;13(11):813-27. doi: 10.1038/nrd4333. Epub 2014 Oct 7. Nat Rev Drug Discov. 2014. PMID: 25287120 Free PMC article. Review.
-
Advancements in nanotheranostics for glioma therapy.Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct 31. doi: 10.1007/s00210-024-03559-w. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39480526 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials